AAAAAA

   
Results: 1-25 | 26-50 | 51-75
Results: 1-25/75
HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE AND THIOTEPA PLUS PBSC IN PATIENTS WITH METASTATIC BREAST-CANCER RESPONDING TO INDUCTION CHEMOTHERAPY
Authors: ROSTI G TIENGHI A VERTOGEN B GIOVANIS P CARIELLO A SABBATINI R RIGGI G MARANGOLO M
Citation: G. Rosti et al., HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE AND THIOTEPA PLUS PBSC IN PATIENTS WITH METASTATIC BREAST-CANCER RESPONDING TO INDUCTION CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 117-117
SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN EBMT PHASE-II STUDY
Authors: LEYVRAZ S PEREY L ROSTI G LANGE A PAMPALLONA S PASINI F BOSQUEE L HUMBLET Y MARANGOLO M
Citation: S. Leyvraz et al., SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - AN EBMT PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 406-406
A SEQUENTIAL CHEMO-RADIOTHERAPEUTIC TREATMENT FOR ANAPLASTIC GLIOMAS - A PHASE-II PILOT-STUDY
Authors: DAZZI C CARIELLO A GIANNINI M GIOVANIS P FIORENTINI G LEONI M ROSTI G TURCI D TIENGHI A MARANGOLO M
Citation: C. Dazzi et al., A SEQUENTIAL CHEMO-RADIOTHERAPEUTIC TREATMENT FOR ANAPLASTIC GLIOMAS - A PHASE-II PILOT-STUDY, Annals of oncology, 9, 1998, pp. 635-635
CHOP IS THE STANDARD REGIMEN IN PATIENTS GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE WITH INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE STUDY-GROUP
Authors: TIRELLI U ERRANTE D VANGLABBEKE M TEODOROVIC I KLUINNELEMANS JC THOMAS J BRON D ROSTI G SOMERS R ZAGONEL V NOORDIJK EM
Citation: U. Tirelli et al., CHOP IS THE STANDARD REGIMEN IN PATIENTS GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE WITH INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 16(1), 1998, pp. 27-34
DETECTION OF BCR-ABL TRANSCRIPT IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS BY REVERSE-TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND CAPILLARY-ELECTROPHORESIS
Authors: MARTINELLI G TESTONI N MONTEFUSCO V AMABILE M SAGLIO G OTTAVIANI E TERRAGNA C BONIFAZZI F DEVIVO A PANE F ROSTI G TURA S
Citation: G. Martinelli et al., DETECTION OF BCR-ABL TRANSCRIPT IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS BY REVERSE-TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND CAPILLARY-ELECTROPHORESIS, Haematologica, 83(7), 1998, pp. 593-601
PRIOR TREATMENT WITH ALPHA-INTERFERON DOES NOT ADVERSELY AFFECT THE OUTCOME OF ALLOGENEIC BMT IN CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA
Authors: ZUFFA E BANDINI G BONINI A SANTUCCI MA MARTINELLI G ROSTI G TESTONI N ZACCARIA A TURA S
Citation: E. Zuffa et al., PRIOR TREATMENT WITH ALPHA-INTERFERON DOES NOT ADVERSELY AFFECT THE OUTCOME OF ALLOGENEIC BMT IN CHRONIC PHASE CHRONIC MYELOID-LEUKEMIA, Haematologica, 83(3), 1998, pp. 231-236
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH EARLY-PHASE HEMATOLOGIC MALIGNANCY - A RETROSPECTIVE COMPARISON OF SHORT-TERM OUTCOME WITH BONE-MARROW TRANSPLANTATION
Authors: LEMOLI RM BANDINI G LEOPARDI G ROSTI G BONINI A FORTUNA A RONDELLI D MANGIANTI S MOTTA MR RIZZI S TASSI C CAVO M REMIDDI C CURTI A CONTE R TURA S
Citation: Rm. Lemoli et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH EARLY-PHASE HEMATOLOGIC MALIGNANCY - A RETROSPECTIVE COMPARISON OF SHORT-TERM OUTCOME WITH BONE-MARROW TRANSPLANTATION, Haematologica, 83(1), 1998, pp. 48-55
HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE ARE AN EFFECTIVE CONDITIONINGREGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHEMOSENSITIVE MULTIPLE-MYELOMA
Authors: CAVO M BANDINI G BENNI M GOZZETTI A RONCONI S ROSTI G ZAMAGNI E LEMOLI RM BONINI A BELARDINELLI A MOTTA MR RIZZI S TURA S
Citation: M. Cavo et al., HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE ARE AN EFFECTIVE CONDITIONINGREGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHEMOSENSITIVE MULTIPLE-MYELOMA, Bone marrow transplantation, 22(1), 1998, pp. 27-32
BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/
Authors: BONINI A BANDINI G ROSTI G RONDELLI D TESTONI N REMIDDI C MOTTA MR RIZZI S MANGIANTI S CAMPANINI E ZUFFA E TURA S
Citation: A. Bonini et al., BIG BU CY IS ASSOCIATED WITH A FAVORABLE LONG-TERM OUTCOME IN PATIENTS ALLOTRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE/, Bone marrow transplantation, 21(11), 1998, pp. 1085-1089
UNRELATED DONOR BMT FOR CML
Authors: DINI G LAMPARELLI T RONDELLI R BARBANTI M GARBARINO L LANINO E GUIDI S ROSTI G ALESSANDRINO EP LOCATELLI F MARENCO P SOLIGO D DIBARTOLOMEO P AVERSA F LANASA G BUSCA A MAJOLINO I DELAURENZI A BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR BMT FOR CML, Bone marrow transplantation, 21, 1998, pp. 112-112
CONCURRENT AND PROSPECTIVE ANALYSIS OF ALLOGENIC PBSC AND BONE-MARROWTRANSPLANTATION (BMT) FOR HEMATOLOGICAL MALIGNANCIES
Authors: BANDINI B RONDELLI D STANZANI M LEMOLI R LEOPARDI G BONIFAZI F REMIDDI C ROSTI G RIZZI S TURA S
Citation: B. Bandini et al., CONCURRENT AND PROSPECTIVE ANALYSIS OF ALLOGENIC PBSC AND BONE-MARROWTRANSPLANTATION (BMT) FOR HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 154-154
IMMUNOCYTOCHEMICAL (ICC) DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW AND PBPC IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY
Authors: FLAMINI E COTIGNOLI T FRASSINETI GL ROSTI G DEPAOLA F MANCINI D
Citation: E. Flamini et al., IMMUNOCYTOCHEMICAL (ICC) DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW AND PBPC IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 21, 1998, pp. 197-197
INFLAMMATORY BREAST-CANCER (IBC) TREATED WITH HIGH-DOSE CHEMOTHERAPY PLUS PBSC SUPPORT - AN ITALIAN MULTICENTER STUDY
Authors: TIENGHI A MARANGOLO M VERTOGEN B MOLINO AM LELLI G SABBATINI R FERRANTE P CARIELLO A ROSTI G
Citation: A. Tienghi et al., INFLAMMATORY BREAST-CANCER (IBC) TREATED WITH HIGH-DOSE CHEMOTHERAPY PLUS PBSC SUPPORT - AN ITALIAN MULTICENTER STUDY, Bone marrow transplantation, 21, 1998, pp. 224-224
A POLICY OF WAIT AND SEE FOR CYTOMEGALOVIRUS ANTIGEMIA POSITIVITY (CMV AG-MARROW TRANSPLANTATION (BMT)() AFTER ALLOGENEIC BONE)
Authors: STANZANI M BANDINI B ROSTI G LEOPARDI G REMIDDI C BONINI A MANGIANTI S TURA S
Citation: M. Stanzani et al., A POLICY OF WAIT AND SEE FOR CYTOMEGALOVIRUS ANTIGEMIA POSITIVITY (CMV AG-MARROW TRANSPLANTATION (BMT)() AFTER ALLOGENEIC BONE), Bone marrow transplantation, 21, 1998, pp. 491-491
CLEARANCE OF HEPATITIS-B VIRUS (HBV) IN HBS AG POSITIVE RECIPIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: BONIFAZI F BANDINI B ROSTI G RONDELLI D REMIDDI C MOTTA MR TURA S
Citation: F. Bonifazi et al., CLEARANCE OF HEPATITIS-B VIRUS (HBV) IN HBS AG POSITIVE RECIPIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Bone marrow transplantation, 21, 1998, pp. 542-542
HIGH-DOSE CHEMOTHERAPY (HDC) WITH HEMATOPOIETIC PROGENITOR-CELL (HPC)SUPPORT IN PATIENTS WITH RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CANCER (UNPC)
Authors: AIROLDI M DECRESCENZO A DALCANTON O ROSTI G AME C DONADIO M BUMMA C
Citation: M. Airoldi et al., HIGH-DOSE CHEMOTHERAPY (HDC) WITH HEMATOPOIETIC PROGENITOR-CELL (HPC)SUPPORT IN PATIENTS WITH RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CANCER (UNPC), Bone marrow transplantation, 21, 1998, pp. 647-647
ALLOGENEIC TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELLS FOR MULTIPLE-MYELOMA - A MULTIVARIATE-ANALYSIS OF RISK-FACTORS ON OUTCOME
Authors: CAVO M BANDINI G LEMOLI RM BENNI M TERRAGNA C LEOPARDI G ROSTI G RONCONI S MARTINELLI G ZAMAGNI E MOTTA MR RIZZI S TURA S
Citation: M. Cavo et al., ALLOGENEIC TRANSPLANTATION WITH BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELLS FOR MULTIPLE-MYELOMA - A MULTIVARIATE-ANALYSIS OF RISK-FACTORS ON OUTCOME, Bone marrow transplantation, 21, 1998, pp. 746-746
PROGNOSIS IN PATIENTS WITH PRIMARY BONE AND OR BONE-MARROW METASTASES(MET) OF RHABDOMYOSARCOMA (RMS) - A JOINT REPORT OF THE EBMT SOLID TUMOR WORKING PARTY AND THE GERMAN SOFT-TISSUE SARCOMA STUDY (CWS)/
Authors: KOSCIELNIAK E ROSTI G TREUNER J HARTMANN O PINKERTON R KLINGEBIEL T MICHON J LADENSTEIN R PHILIP T
Citation: E. Koscielniak et al., PROGNOSIS IN PATIENTS WITH PRIMARY BONE AND OR BONE-MARROW METASTASES(MET) OF RHABDOMYOSARCOMA (RMS) - A JOINT REPORT OF THE EBMT SOLID TUMOR WORKING PARTY AND THE GERMAN SOFT-TISSUE SARCOMA STUDY (CWS)/, Bone marrow transplantation, 21, 1998, pp. 792-792
A MULTIVARIATE AND MATCHED-PAIR ANALYSIS ON HIGH-RISK EWING-TUMOR (ET) PATIENTS UNDERGOING MGT SCR IN EUROPE/
Authors: LADENSTEIN R HARTMANN O PINKERTON R MICHON J DALLORSO G BURDACH S ROSTI G PHILIP T
Citation: R. Ladenstein et al., A MULTIVARIATE AND MATCHED-PAIR ANALYSIS ON HIGH-RISK EWING-TUMOR (ET) PATIENTS UNDERGOING MGT SCR IN EUROPE/, Bone marrow transplantation, 21, 1998, pp. 796-796
HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - FINAL RESULTS OF THE EBMT PHASE-II STUDY
Authors: LEYVRAZ S PEREY L ROSTI G LANGE A PAMPALLONA S PASINI F BOSQUEE L HUMBLET Y MARANGOLO M
Citation: S. Leyvraz et al., HIGH-DOSE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - FINAL RESULTS OF THE EBMT PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 800-800
HIGH-DOSE THERAPY (HDT) WITH STEM-CELL RESCUE IN POOR-RISK WILMS-TUMOR (WT) - AN EBMT SOLID TUMOR WP REGISTRY UPDATE AT JUNE 1997
Authors: DALLORSO S SERRA IB BARANZELLI MC BEKASSY A BEGUIN Y BIRON P CASTEL V DEVALCK C FASTH A HARTMANN O HERO B KOSCIELNIAK E KREMENS B MICHON J NIEDERWEISER D NIETHAMMER D REMES K FERRANTE P ROSTI G
Citation: S. Dallorso et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL RESCUE IN POOR-RISK WILMS-TUMOR (WT) - AN EBMT SOLID TUMOR WP REGISTRY UPDATE AT JUNE 1997, Bone marrow transplantation, 21, 1998, pp. 806-806
THE EBMT SOLID TUMORS WORKING PARTY AND REGISTRY ACTIVITY - 1997 REPORT
Authors: ROSTI G FERRANTE P LADENSTEIN R KOSCELNIAK E LEYVRAZ S LEDERMANN J ROCHE H BIRON P NIEDERWIESER D CROWN J CHAUVIN F
Citation: G. Rosti et al., THE EBMT SOLID TUMORS WORKING PARTY AND REGISTRY ACTIVITY - 1997 REPORT, Bone marrow transplantation, 21, 1998, pp. 812-812
TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (RH-TPA) - AN EXPERIENCE OF 6 PATIENTS
Authors: GHERLINZONI F VIANELLI N BANDINI G ROSTI G CATANI L LEOPARDI G VALDRE L TURA S
Citation: F. Gherlinzoni et al., TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (RH-TPA) - AN EXPERIENCE OF 6 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 841-841
INTERACTIVE ORGANIZATION BETWEEN NURSES STAFF AND PATIENTS UNDERGOINGPBPC HARVESTING
Authors: GIANNOTTI F CAVALLARO M ROSTI G ZAMBIANCHI M TIBERIO A GESSI B IMOLA N MARANGOLO M
Citation: F. Giannotti et al., INTERACTIVE ORGANIZATION BETWEEN NURSES STAFF AND PATIENTS UNDERGOINGPBPC HARVESTING, Bone marrow transplantation, 21, 1998, pp. 977-977
UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DINI G LAMPARELLI T RONDELLI R LANINO E BARBANTI M COSTA C MANFREDINI L GUIDI S ROSTI G ALESSANDRINO EP LOCATELLI F MARENCO P SOLIGO D DIBARTOLOMEO P AVERSA F LANASA G BUSCA A MAJOLINO I DELAURENZI A BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 544-552
Risultati: 1-25 | 26-50 | 51-75